medicine
medicine Clean energy Investment
EN/CN
Medicine
Medicine Clean energy Investment
首页 Oncology
立幸-盐酸多柔比星脂质体注射液
国药准字：H20123273、H20173060适应症：本品可用于低CD4(＜200CD4淋巴细胞/mm3)及有广泛皮肤粘膜内脏疾病的与艾滋病相关的卡波氏肉瘤(AIDS-KS)病人。简介：国内最成熟和领先的新型蒽环类脂质体注射液；显著降低传统蒽环类药物心脏毒性、脱发、骨髓抑制等不良反应；ERP效应高，增强药物抗肿瘤作用。
Related literature
Related Consensus
About us
Group Profile Development Party Affairs Material Download
Innovation
Macromolecule Micromolecule Innovative Technology
Capabilities
Core Competence Platform Enterprise Management System
Products
Rx OTC
News
Company Release Media Coverage Information Disclosure
CSR
Responsibility Social Welfare
Talents
Talent Management Enterprise University Join Us
About us

Nanchang National High-tech Industrial
Development Zone, Jiangxi Province,
China No. 3333, West Yaohu Avenue
Tel:0791-87339727
Fex:0791-87339712
Email:service@jemincare.com(PR)

© 2021 Jiangxi Jemincare Group Co., Ltd. All rights reserved. Gan ICP Record No. 12005131 Gong Wang An Record No.: 36010902000270 Contact Us
Qualification Certificate for Internet Drug Information Services: (Gan) Non-for-profit–2018-0003 Powered by AiBULLS